Status:
COMPLETED
Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment
Lead Sponsor:
University of Utah
Collaborating Sponsors:
PriCara, Unit of Ortho-McNeil, Inc.
Conditions:
Laryngopharyngeal Reflux
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This study proposes to investigate prospectively, the presence of molecular markers for inflammation in laryngopharyngeal reflux (LPR) patients and to study the effect of a proton pump inhibitor (Acip...
Detailed Description
Objectives: This study proposes to investigate prospectively, the presence of molecular markers for inflammation in LPR patients and to study the effect of a proton pump inhibitor on these molecular ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- The subject group will consist of 25 subjects who have untreated LPR diagnosed by laryngoscopic assessment and 24-hour pH probe.
Exclusion
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00204698
Start Date
August 1 2003
End Date
May 1 2006
Last Update
January 16 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah
Salt Lake City, Utah, United States, 84132